Laurus Labs
-
{
- All
- News
-
10% Returns In Five Days: This Pharma Stock Hits Record High After Q1 Results
- Tuesday July 28, 2026
- Author: Soumil Kamat
Laurus Labs shares rose 2% to a 52-week high following strong Q1 FY27 results, with revenue up 29% year-on-year to Rs 2,026 crore.
-
www.ndtvprofit.com
-
72% Return in Six Months: This Stock Jumps Over 7%, Hits 52-Week High After Q1 Results
- Monday July 27, 2026
- Author: Tanmay Tiwary
On its KRKA joint venture, the company said construction of the FDF manufacturing site is progressing as planned, with Phase-I production blocks expected to commence operations by mid-2027.
-
www.ndtvprofit.com
-
Laurus Labs Shares Surge 6% To Hit One-Year High As Brokerages Hike Target On Q4 Profit Beat
- Monday May 4, 2026
- Author: Nikita Prasad
Laurus Labs trades at its highest price in the last one year after brokerages such as HDFC Securities and Choice Institutional Equities hiked the target price on CDMO-led growth volumes during the March quarter.
-
www.ndtvprofit.com
-
Laurus Labs May Rally 35% Says Motilal Oswal — Key Triggers And Target Price Inside
- Friday March 20, 2026
- Author: Motilal Oswal Financial Services
Laurus is witnessing a strong scale-up in CDMO business from global innovator pharma, including rare formulation-level contracts for patented products, adds Motilal Oswal.
-
www.ndtvprofit.com
-
Lupin, Zydus Lifesciences Among DRChoksey’s Top Picks As Pharma Sector Braces For Q3 — Check Full List
- Wednesday January 7, 2026
- Author: Deven Choksey Research
Other notable picks include Alembic Pharma which is expected to benefit from specialty optionality and margin improvement.
-
www.ndtvprofit.com
-
Laurus Labs Q2: Shares Fall Over 3% Despite Surge In Net Profit
- Friday October 24, 2025
- Author: NDTV Profit Desk
The company's consolidated revenue rose 35.1% year-on-year to Rs 1,653.47 crore and net profit surged 883% to Rs 194.97 crore.
-
www.ndtvprofit.com
-
Laurus Labs Q2 Review: Healthy Momentum In CDMO, FDF; Earnings Upcycle Intact — Motilal Oswal Maintains 'Buy'
- Friday October 24, 2025
- Author: Motilal Oswal Financial Services
Motilal Oswal maintains 'Buy' on Laurus Labs, sees upto 19% upside potential.
-
www.ndtvprofit.com
-
Stock Picks Today: Cipla, HUL, Colgate, Laurus Labs, Bharat Forge, Auto And Airlines on Brokerages' Radar
- Friday October 24, 2025
- Author: NDTV Profit Research
Cipla, Hindustan Unilever Ltd., Colgate, Laurus Labs, Bharat Forge, and the Auto and Airlines sectors are drawing brokerage commentary today.
-
www.ndtvprofit.com
-
Diwali Muhurat Stock Picks 2025: Paytm, NMDC To Syrma — Top 12 Bets By Axis Securities For Samvat 2082
- Wednesday October 15, 2025
- Author: Axis Securities
Axis Securities expects these stocks to deliver potential upsides ranging from 25% to 56% .
-
www.ndtvprofit.com
-
Laurus Labs Downplays Impact Of New US Pharma Tariffs On Branded Drugs
- Friday September 26, 2025
- Author: Shubhayan Bhattacharya
Lauras Labs derives 40% of its revenue from antiretroviral (ARV) drugs, which remain insulated from US tariffs.
-
www.ndtvprofit.com
-
Stock Picks Today: Sun Pharma, ICICI Bank, Bajaj Finance, Afcons, Yes Bank, Laurus Labs On Brokerages' Radar
- Thursday September 18, 2025
- Author: NDTV Profit Research
Avenue Supermarts Ltd., Shriram Finance Ltd., and Laurus Labs Ltd. are among the companies garnering brokerage commentary today.
-
www.ndtvprofit.com
-
Indian Pharma Exports Surge In August: Laurus, Divi's Lead Growth
- Tuesday September 16, 2025
- Author: NDTV Profit Desk
Neuland Laboratories Ltd. reported exports worth $12 million in August 2025, marking a massive 433% year-on-year growth and a 250% month-on-month surge.
-
www.ndtvprofit.com
-
10% Returns In Five Days: This Pharma Stock Hits Record High After Q1 Results
- Tuesday July 28, 2026
- Author: Soumil Kamat
Laurus Labs shares rose 2% to a 52-week high following strong Q1 FY27 results, with revenue up 29% year-on-year to Rs 2,026 crore.
-
www.ndtvprofit.com
-
72% Return in Six Months: This Stock Jumps Over 7%, Hits 52-Week High After Q1 Results
- Monday July 27, 2026
- Author: Tanmay Tiwary
On its KRKA joint venture, the company said construction of the FDF manufacturing site is progressing as planned, with Phase-I production blocks expected to commence operations by mid-2027.
-
www.ndtvprofit.com
-
Laurus Labs Shares Surge 6% To Hit One-Year High As Brokerages Hike Target On Q4 Profit Beat
- Monday May 4, 2026
- Author: Nikita Prasad
Laurus Labs trades at its highest price in the last one year after brokerages such as HDFC Securities and Choice Institutional Equities hiked the target price on CDMO-led growth volumes during the March quarter.
-
www.ndtvprofit.com
-
Laurus Labs May Rally 35% Says Motilal Oswal — Key Triggers And Target Price Inside
- Friday March 20, 2026
- Author: Motilal Oswal Financial Services
Laurus is witnessing a strong scale-up in CDMO business from global innovator pharma, including rare formulation-level contracts for patented products, adds Motilal Oswal.
-
www.ndtvprofit.com
-
Lupin, Zydus Lifesciences Among DRChoksey’s Top Picks As Pharma Sector Braces For Q3 — Check Full List
- Wednesday January 7, 2026
- Author: Deven Choksey Research
Other notable picks include Alembic Pharma which is expected to benefit from specialty optionality and margin improvement.
-
www.ndtvprofit.com
-
Laurus Labs Q2: Shares Fall Over 3% Despite Surge In Net Profit
- Friday October 24, 2025
- Author: NDTV Profit Desk
The company's consolidated revenue rose 35.1% year-on-year to Rs 1,653.47 crore and net profit surged 883% to Rs 194.97 crore.
-
www.ndtvprofit.com
-
Laurus Labs Q2 Review: Healthy Momentum In CDMO, FDF; Earnings Upcycle Intact — Motilal Oswal Maintains 'Buy'
- Friday October 24, 2025
- Author: Motilal Oswal Financial Services
Motilal Oswal maintains 'Buy' on Laurus Labs, sees upto 19% upside potential.
-
www.ndtvprofit.com
-
Stock Picks Today: Cipla, HUL, Colgate, Laurus Labs, Bharat Forge, Auto And Airlines on Brokerages' Radar
- Friday October 24, 2025
- Author: NDTV Profit Research
Cipla, Hindustan Unilever Ltd., Colgate, Laurus Labs, Bharat Forge, and the Auto and Airlines sectors are drawing brokerage commentary today.
-
www.ndtvprofit.com
-
Diwali Muhurat Stock Picks 2025: Paytm, NMDC To Syrma — Top 12 Bets By Axis Securities For Samvat 2082
- Wednesday October 15, 2025
- Author: Axis Securities
Axis Securities expects these stocks to deliver potential upsides ranging from 25% to 56% .
-
www.ndtvprofit.com
-
Laurus Labs Downplays Impact Of New US Pharma Tariffs On Branded Drugs
- Friday September 26, 2025
- Author: Shubhayan Bhattacharya
Lauras Labs derives 40% of its revenue from antiretroviral (ARV) drugs, which remain insulated from US tariffs.
-
www.ndtvprofit.com
-
Stock Picks Today: Sun Pharma, ICICI Bank, Bajaj Finance, Afcons, Yes Bank, Laurus Labs On Brokerages' Radar
- Thursday September 18, 2025
- Author: NDTV Profit Research
Avenue Supermarts Ltd., Shriram Finance Ltd., and Laurus Labs Ltd. are among the companies garnering brokerage commentary today.
-
www.ndtvprofit.com
-
Indian Pharma Exports Surge In August: Laurus, Divi's Lead Growth
- Tuesday September 16, 2025
- Author: NDTV Profit Desk
Neuland Laboratories Ltd. reported exports worth $12 million in August 2025, marking a massive 433% year-on-year growth and a 250% month-on-month surge.
-
www.ndtvprofit.com